Floseal ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 227 | Osler disease | 1 |
227. Osler disease
Clinical trials : 54 / Drugs : 73 - (DrugBank : 21) / Drug target genes : 23 - Drug target pathways : 136
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02638012 (ClinicalTrials.gov) | December 2015 | 13/10/2015 | Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) | Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) | Hereditary Hemorrhagic Telangiectasia (HHT);Epistaxis | Drug: Floseal;Other: Packing | St. Michael's Hospital, Toronto | The Ottawa Hospital | Completed | 18 Years | N/A | All | 8 | N/A | Canada |